Abstract:BACKGROUND: Dexmedetomidine as an adjuvant can improve the duration and the quality of thoracic paravertebral block (TPVB); however, its quantitative effect on propofol infusion is unclear. This study aimed to investigate the effect of dexmedetomidine as an adjuvant in TPVB on the medium effective concentration (EC50) of propofol for successful laryngeal mask insertion.METHODS: Sixty breast cancer patients who underwent elective modified radical mastectomy were enrolled and randomized at a 1:1 ratio into control group (Group C, n=30) or dexmedetomidine group (Group D, n=30). Ultrasound-guided T3 paravertebral block was performed before induction of anesthesia. In Group C, 0.5% ropivacaine 0.3 mL/kg was injected into T3 paravertebral space, while subjects in Group D received 0.5% ropivacaine 0.3 mL/kg with dexmedetomidine (1 µg/kg). Propofol target-controlled infusion (TCI) was performed, with an initial target effect-site concentration of 5 µg/mL determined for both groups. The laryngeal mask was inserted once the effect chamber achieved the target concentration. Subsequent target concentrations were adjusted by Dixon up-down sequential method, where dose modifications were performed by 0.5 mg/mL intervals, based on the success of the laryngeal mask insertion. Probit analysis was used to determine the propofol EC50. Mean arterial pressure (MAP), heart rate (HR), bispectral index (BIS) and application of atropine or ephedrine was recorded. Participants, TPVB giver, and data recorder were blinded to group assignment.RESULTS: Propofol EC50 for successful laryngeal mask insertion were statistically significant, with 5.256 µg/mL (95% CI: 4.833, 5.738 µg/mL) in Group C and 3.172 µg/mL (95% CI: 2.701, 3.621 µg/mL) in Group D. Both groups displayed significantly lower MAP and HR, post propofol TCI (P<0.05). However, subjects in Group D exhibited lower MAP and HR levels compared to patients in Group C (P<0.05). Application of atropine (0% <i>vs.</i> 10%) and ephedrine (20.0% <i>vs.</i> 13.3%) were not significantly different between two groups.CONCLUSIONS: Dexmedetomidine, administered as an adjuvant in TPVB, can reduce the TCI concentration of propofol for successful laryngeal mask placement in females. The target concentration of propofol requires adjustment and close monitoring of hemodynamic changes, post induction is warranted.TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1800016614.

Multipoint Transcutaneous Electrical Stimulation Reduces Median Effective Plasma Concentration of Propofol: A Randomised Clinical Trial

Effect of Transcutaneous Electrical Acupoint Stimulation on Sedative Efficacy During Induction of Anesthesia with Propofol

A comparison between target-controlled and manually controlled propofol infusions in patients undergoing routine surgical procedures.

Effect of target-controlled effect-site concentration of propofol on hemodynamics

The Accuracy of Target-Controlled Infusion of Propofol in Chinese

Comparison of the Effectiveness of Dexmedetomidine Versus Propofol Target-Controlled Infusion for Sedation During Coblation-Assisted Upper Airway Procedure.

Pharmacodynamics of TCI of Propofol with Different Pharmacokinetic Parameter Sets During Epidural Anesthesia

Effect of Different Target Plasma Concentrations of Remifentanil on Sedative Effect of Propofol

Effects of dexmedetomidine as an adjuvant in thoracic paravertebral block on EC50 of propofol for successful laryngeal mask insertion: a randomized controlled trial

[Pharmacodynamic Interaction Between Propofol and Remifentanil on the Tolerance Response to Electrical Tetanus Stimuli].

Target-controlled infusion with propofol for conscious sedation in patients undergoing epidural anesthesia

Effects of Different Doses of Dexmedetomidine on EC50 of Propofol Given by Target-Controlled Infusion at Loss of Consciousness

Effects of Transcutaneous Electrical Acupuncture Point Stimulation on Peripheral Capillary Oxygen Saturation in Elderly Patients Undergoing Colonoscopy with Sedation: a Prospective Randomized Controlled Trial

Target-controlled Infusions of Remifentanil and Propofol During Thoracic Surgery

Effects of Transcutaneous Electrical Acupoint Stimulation on Stress Response during Intubation and Extubation in Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Prospective, Randomized Controlled Trial

The effects of propofol and isoflurane on intraoperative motor evoked potentials during spinal cord tumour removal surgery - A prospective randomised trial

The Preventive Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Delirium in Elderly Patients with Time Factors: A Randomized Trial.

[Effect of Transcutaneous Acupoint Electrical Stimulation Combined with Target Controlled Infusion of Propofol on Efficacy of General Anesthesia for Craniotomy].

[The Anesthesiologic Value of Transcutaneous Acupoint Electrical Stimulation Combined with General Intravenous Anesthesia in Endoscopic Thyroidectomy Patients: a Clinical Study].

The Difference Between Target and Measured Concentrations of Propofol Administered by TCI: an Evaluation of the Performance of the TCI System

Influence of Remifentanil on Cp50 of Propofol Given by Target-Controlled Fusion for Loss of Consciousness